EU Commission Publishes Stringent New Common Specifications Requirements for Reprocessing Single-Use Devices, Making In-House Hospital Reprocessing “Difficult if not Impossible” EU Ministries of Health Face Choice: Increase Medical Waste and Cost by Using Only Original Devices or “Opt-in” to Allow Hospitals to Partner with Regulated Remanufacturers for CE Marked, Safe Reuse of Approved Single-Use Devices […]
Read More… from New EU rules for reprocessing Single-Use Devices
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy. A team of researchers led by Rudolf Valenta from MedUni Vienna’s Center for Pathophysiology, Infectiology and Immunology has now demonstrated that a protein contained in the BM32 vaccine against grass pollen allergy induces antibodies that prevent the hepatitis […]
Read More… from Chronic hepatitis B: vaccine against grass pollen allergy potential treatment
More action needed on pharmacy risk assessments: – A new survey carried out by the Royal Pharmaceutical Society (RPS) and the UK Black Pharmacists Association (UKBPA) has found that pharmacy teams are still not receiving adequate individual COVID-19 risk assessments. The data reveals a varied picture in terms of pharmacists’ experience and views of COVID-19 […]
Read More… from More action needed on pharmacy risk assessments
Natasha Meredith reports that scientists have developed a new computational technique that can be used to enhance the effectiveness of bacteria used in biotechnological applications. Publishing their findings in the journal Nature Chemical Biology, scientists from the University of Surrey and Universidad Nacional Autónoma de México have developed a new computational technique, ReProMin, to identify processes […]
Read More… from New computational technique improves bacteria to develop medication
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79% lower risk of developing severe disease compared to placebo Patients who received SNG001 were more than twice as likely to recover from COVID-19 as those on placebo Southampton, UK – 20 July 2020: Synairgen plc (LSE: […]
Read More… from Positive results from trial of SNG001 in COVID-19 patients
Ambitious annual target on HIV treatment could be achieved for equivalent of just one month of global spend on HIV drugs The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at least 95% of those living with HIV globally would be able to receive treatment. […]
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer. The decision puts the NHS in England and Wales out […]
Read More… from Prostate cancer treatment abiraterone not available
Urgent action needed on BAME workforce risk assessments: According to a new survey from the Royal Pharmaceutical Society (RPS) and the UK Black Pharmacists Association (UKBPA), more than two-thirds of Black, Asian and Minority Ethnic (BAME) pharmacists working in primary care and hospitals still have not yet had potentially lifesaving COVID-19 workplace risk assessments months […]
Read More… from Urgent action needed on BAME workforce risk assessments
Cancers are often heavily reliant on breaking down fats for their growth and spread, and could be treated by a highly innovative combination of new drugs and dietary changes, a major new study concludes. Analysing cancer’s metabolism with a surgical ‘iKnife’ detects tumours with heavy reliance on fats Landmark study finds metabolic weakness could be […]
Read More… from Cancer’s reliance on fats could lead to new ‘drugs and diet’ treatment
A new peer-reviewed study using medicinal cannabidiol in children and adolecents with intellectual disabilities has found that it may reduce the severity of their behavioural problems. A new study has shown that cannabidiol, a cannabis-derived supplement, may reduce the severity of behavioural problems in children and adolescents with an intellectual disability The supplement was found […]